Apple Launches AI Health Study With OpenEvidence

Apple Launches AI Health Study to Examine User Trust & Response Quality

Apple Launches AI Health Study to Examine User Trust & Response Quality

The research will also explore whether conversational AI can help people prepare for doctor's appointments, offering insights into how consumer-facing AI tools may support discussions between patients and clinicians.

Apple has launched a new AI health research study in the United States to understand how people interact with conversational AI tools for medical information.

Developed with clinical AI platform OpenEvidence, the study will assess response quality, user trust and comprehension, with participation open to up to 200,000 eligible adults.

The study has been designed to examine whether AI can communicate complex medical information in a way that people can understand and use.

Participants will be able to review answers generated by OpenEvidence, which draws on established medical literature, including publications such as The New England Journal of Medicine, the Journal of the American Medical Association and Nature.

The research will also explore whether integrating personal health information can make AI responses more relevant. Participants can choose to share HealthKit data, including resting heart rate, physical activity, sleep metrics and laboratory results.

The study will assess how access to these data influences users' understanding of and engagement with AI-generated health information.

Another area of investigation is whether conversational AI can help people prepare for appointments with their doctors. The findings could offer insights into how consumer-facing AI tools may support discussions between patients and clinicians without replacing professional medical advice.

“At Apple, we believe responsible innovation starts with scientific rigour and clinical grounding. Health is deeply personal, and conducting a dedicated research study is the most thoughtful way to understand how people engage with, comprehend, and evaluate health AI in everyday life,” said Sumbul Desai, M.D., Apple’s vice president of Health and Fitness. “Insights from this study will help advance the broader scientific conversation and ensure that as technology evolves, we continue building trusted tools that genuinely support people wherever they are on their health journey.”

OpenEvidence brings clinical AI capabilities to the collaboration, while Apple has developed the research experience.

The study includes privacy safeguards and clinical safety measures. Apple has stated that study data will not be used to train AI models.

Participants retain control over whether they share HealthKit metrics and survey responses, while the app's safety guardrails are designed to identify certain concerning questions and direct users towards healthcare providers or other appropriate resources.

The Apple Health AI Usage Study is open to eligible participants aged 21 and older in the United States, with enrolment capped at 200,000.

The findings are intended to inform the responsible development of health AI experiences for Apple and the wider industry.

Stay tuned for more such updates on Digital Health News

Follow us

More Articles By This Author


Show All

Welcome back.

Pick up where you left off on Digital Health News.

Sign in to DHN

For existing DHN and DHN Plus members.

or
Continue with Google
New to DHN?